Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bruce Conklin
University of California Berkeley, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tenaya Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
These SFIs could impact the design, conduct, and reporting of research under R01HL130417 as determined by a review of Gladstone’s Conflict of Interest Committee because of common biology being investigated.
Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity
Project Narrative: This proposal attempts to establish an in vitro model of the human heart tissue that will have a significant impact on the early screening of chemotherapeutic candidate drugs and assessing their cardiac toxicity. We will use cells from cardiomyopathy patients with diverse backgrounds, as a step to using our device to advance the goals of personalized medicine.
Filed on February 06, 2017.
Tell us what you know about Bruce Conklin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Bruce Conklin”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Bruce Conklin | J. David Gladstone Institutes | Conflict of Interest | Tenaya Therapeutics | $80,000 - $99,999 |
| Bruce Conklin | University of California Berkeley | Conflict of Interest | Tenaya Therapeutics | $80,000 - $99,999 |
| Bruce Conklin | J. David Gladstone Institutes | Conflict of Interest | Tenaya Therapeutics | Value cannot be readily determined |
| Bruce Conklin | University of California Berkeley | Conflict of Interest | Tenaya Therapeutics | $80,000 - $99,999 |
| Bruce Conklin | University of California Berkeley | Conflict of Interest | Tenaya Therapeutics | Value cannot be readily determined |
| Bruce Conklin | J. David Gladstone Institutes | Conflict of Interest | Tenaya Therapeutics | $80,000 - $99,999 |
| Bruce Conklin | J. David Gladstone Institutes | Conflict of Interest | Tenaya Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.